Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

PONV: later-stage trial registry

1 of 4 indexed PONV trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count

PONV: 4 US clinical trials tracked, 1 recruiting.

PONV is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Acacia Pharma, running 2 of these trials.

Enrollment posture brief

Registry condition ponv

OPEN 1 | RECR 25% | LATE 3 | EARLY 0 | RANK #4115 | SPON 2

Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%PONV (this)25%
Open-enrollment share among volume-matched conditions near PONV

PONV lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for PONV on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. PONV is recruiting below its size-band peers.

    1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 33

Phase Distribution

PhaseTrial count
Phase 3 3

Top Sponsors

Acacia Pharma 2 trials
Jyoti Pandya 1 trials
TriHealth 1 trials

Named interventions

Most-linked intervention names on PONV records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
3 trials
APD421- Amisulpride for IV injection Drug
1 trials
APD421 Drug
1 trials
No TEAS Other
1 trials
TEAS via ES-130 Device
1 trials
Dexamethasone Drug
1 trials

US sites by state

Facility locations filed on PONV trials. A trial with sites in several states counts in each.

Ohio 3 trials
North Carolina 2 trials
Texas 1 trials
New York 1 trials
Massachusetts 1 trials
Kansas 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this PONV page

4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This PONV condition card totals 4 registered trials; most-linked intervention Placebo; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.